T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $883B
1-Year Return 25.8%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Quarter Return
+6.04%
1 Year Return
+25.8%
3 Year Return
+128.18%
5 Year Return
+198.37%
10 Year Return
+601.91%
AUM
$836B
AUM Growth
+$19.9B
Cap. Flow
-$11B
Cap. Flow %
-1.32%
Top 10 Hldgs %
35.57%
Holding
3,092
New
135
Increased
1,850
Reduced
836
Closed
112

Sector Composition

1 Technology 34%
2 Healthcare 14.89%
3 Financials 10.35%
4 Consumer Discretionary 10.1%
5 Communication Services 9.22%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ALPN
2951
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
-3,080,220
Closed -$122M
MDC
2952
DELISTED
M.D.C. Holdings, Inc.
MDC
-51,013
Closed -$3.21M
AAOI icon
2953
Applied Optoelectronics
AAOI
$1.5B
$0 ﹤0.01%
+11,828
New
ABSI icon
2954
Absci
ABSI
$368M
$0 ﹤0.01%
+25,586
New
ACET icon
2955
Adicet Bio
ACET
$60M
-15,344
Closed -$37K
ACHV icon
2956
Achieve Life Sciences
ACHV
$145M
$0 ﹤0.01%
+11,085
New
ACWI icon
2957
iShares MSCI ACWI ETF
ACWI
$22.1B
-14,893
Closed -$1.64M
ADCT icon
2958
ADC Therapeutics
ADCT
$398M
$0 ﹤0.01%
+22,476
New
APLT icon
2959
Applied Therapeutics
APLT
$68.2M
$0 ﹤0.01%
+30,675
New
APO.PRA icon
2960
Apollo Global Management Series A
APO.PRA
$2B
0
-$16.3M
AQST icon
2961
Aquestive Therapeutics
AQST
$656M
$0 ﹤0.01%
+23,848
New
ASIX icon
2962
AdvanSix
ASIX
$569M
-7,507
Closed -$215K
ASPI icon
2963
ASP Isotopes
ASPI
$755M
$0 ﹤0.01%
+12,812
New
ASRT icon
2964
Assertio
ASRT
$76.8M
-22,028
Closed -$22K
ATOS icon
2965
Atossa Therapeutics
ATOS
$102M
$0 ﹤0.01%
+40,770
New
ATRA icon
2966
Atara Biotherapeutics
ATRA
$90.7M
-198,326
Closed -$3.44M
AVDL
2967
Avadel Pharmaceuticals
AVDL
$1.53B
$0 ﹤0.01%
+29,391
New
BCAB icon
2968
BioAtla
BCAB
$31.5M
-12,791
Closed -$45K
BIRD icon
2969
Allbirds
BIRD
$51M
-1,299
Closed -$19K
BKKT icon
2970
Bakkt Holdings
BKKT
$122M
-655
Closed -$8K
BLND icon
2971
Blend Labs
BLND
$1.05B
$0 ﹤0.01%
+73,605
New
BLZE icon
2972
Backblaze
BLZE
$491M
$0 ﹤0.01%
+12,788
New
BN icon
2973
Brookfield
BN
$99.5B
-109,552
Closed -$4.59M
BUR icon
2974
Burford Capital
BUR
$2.92B
$0 ﹤0.01%
+63,669
New
BVS icon
2975
Bioventus
BVS
$481M
$0 ﹤0.01%
+12,041
New